biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Post by TechnicalBuyon Jul 12, 2013 10:30am

353 Views

Post# 21604093

MDG.TO received an offer for $357m

Good morning,

Medicago got an offer for $357m this am. This is a great development for the Canadian biotech sectory, but also BTI as there are a number of investors invested in both companies. We will likely see some transfer of profits into this and other (ICO.V, KNE.V, DMA.V) stories.

TB
Follow me on twitter at @TechnicalBuy

Bullboard Posts

Barrick Gold employees detained in Mali amid ongoing dispute